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Histiocytic skin disorders are usually classified as either 
Langerhans’ cell histiocytosis (LCH) or non LCH, based on 
the pathology. Benign cephalic histiocytosis (BCH) is a rare 
type of non-Langerhans histiocytitic disorder and is 
characterized by self-healing multiple small eruptions of 
yellow to red-brown papules on the face and upper trunk. 
Histologic features of this disorder show dermal proliferation 
of histiocytes that have intracytoplasmic comma-shaped 
bodies, coated vesicles and desmosome-like structures. In 
this study, we report on a 7-month-old boy who contained 
small yellow-red papules on his face that spread to his upper 
trunk. The clinical and histologic features in this patient were 
consistent with BCH. (Ann Dermatol 23(4) 508∼511, 2011)
-Keywords-
Benign cephalic histiocytosis, Generalized eruptive histio-
cytoma, Infant, Juvenile xanthogranuloma, Non-Langerhans- 
Cell
INTRODUCTION
Benign cephalic histiocytosis (BCH) is a rare, benign 
non-Langerhans histiocytitic disorder of infants and young 
children, and was first described by Gianotti et al. in 
1971
1. This disorder is characterized by a self-healing, 
asymptomatic and multiple small eruptions of yellow to 
red-brown papules, which develops initially on the head 
and neck. Histological studies have shown that dermal 
proliferation of histiocytes, which have intracytoplasmic 
comma-shaped bodies, coated vesicles and desmosome- 
like structure, occurs with this disorder
2. There have been 
reports showing that BCH may have overlapping clinical 
and histologic features with some other non-Langerhans 
histiocytitic disorders, including juvenile xanthogranu-
loma (JXG) and generalized eruptive histiocytoma (GEH)
3. 
Here, we describe a 7-month-old boy that had clinico-
pathologic findings consistent with the diagnosis of BCH.
CASE REPORT
A 7-month-old white boy was referred to our department 
with small discrete, asymptomatic, yellow-red papules, 
which were first observed on his face at 1 month. The 
number of papules gradually increased over the following 
weeks and spread to his upper trunk and upper arms. He 
was otherwise healthy and developmentally normal. Both 
his weight and height were at the 50th percentile. His 
parents were not consanguineous and the family history 
was unremarkable. Clinical examination at the time of 
presentation demonstrated multiple, scattered yellow-red 
monomorphic papules that were 2 to 5 mm over the face, 
upper trunk and upper limbs (Fig. 1, 2). Mucous mem-
branes, palms, soles and teeth were normal. He had no 
organomegaly or lymphadenopathy. Neurodevelopmental 
and ophthalmic examinations were normal.
In the routine blood test, the haematologic and bio-
chemical results were normal. Serum lipid screening 
(cholesterol, triglycerides, High-density lipoprotein (HDL)- 
and low-density lipoprotein (LDL)-cholesterol), IgA, IgG, 
IgM, serum protein electrophoresis and syphilis serology 
were all normal or negative. X-ray screening of skeletal 
system showed no bony defects. An upper abdominal 
ultrasonography was interpreted to be normal.
Histological examination of the biopsy specimen taken Benign Cephalic Histiocytosis
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Fig. 1. Small yellow-red papules scattered on the face, forehead
and chin.
Fig. 2. Discrete small yellow-red papules seen on the upper back.
Fig. 3. Proliferations of pleomorphic epitheliod histiocytic cells 
within the upper- and mid-dermis (H&E, original magnification 
×100).
Fig. 4. Immunohistochemistry was positive stained for CD68 
(biotin-streptavidin peroxidase system, DAB, original magnifi-
cation ×200).
from a lesion on the left shoulder showed a normal 
epidermis and sufficient proliferation of large, pleo-
morphic epitheliod histiocytic cells with large cytoplasm 
within the upper- and mid-dermis without epidermo-
tropism. Mitotic figures, multinucleated giant cells and 
cytoplasmic lipids were absent. There was an interstitial 
infiltration of moderate numbers of lymphocytes and 
scattered eosinophils (Fig. 3). In the immunohistoche-
mistry analysis, the cells were stained positive for CD68, 
but negative for the S100 protein and CD1a (Fig. 4). 
According to the clinicopathologic findings, the disease 
was diagnosed as benign cephalic histiocytosis, a type of 
non-Langerhans cell histiocytic disorder. 
Three months after his initial visit, none of the skin lesions 
had regressed and new lesions developed on the upper 
trunk and upper limbs. 
DISCUSSION
BCH is a rare non-Langerhans cell histiocytosis of unknown 
etiology that is presented as a self-healing eruption in the 
head and neck
2. Since the initial description of this 
disorder by Gianotti et al. there have been 42 reported 
cases in various races in the English language literature
2,4,5. 
The clinical findings are asymptomatic, macules and 
papules that are 1∼8 mm in diameter with colors ranging 
from yellow to red brown, which first appear on the upper 
half of the body, mainly on the face and neck. Lesions 
may subsequently extent to the upper and lower extre-
mity, and buttocks. Consistent with other reported cases, R Koca, et al
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our patient had multiple, 2 to 5 mm yellow-red mono-
morphic papules that first appeared on the face and later 
spread onto the upper part of the body and upper 
extremities. Mucous membranes, palms, soles, and 
visceral organs have not been reported to be involved in 
this disease
6-9. The lesions appear at ages ranging from 2 
to 66 months (average 15 months). In approximately 50% 
of cases, the patients are younger than 6 months. Males 
and females are affected equally. Spontaneous regression 
of lesions begins on an average between 8 to 48 months 
and complete regression occurs on an average at 50 
months, leaving hyperpigmented macules, but not scars
2. 
Unfortunately, in our case, we only did a follow-up after 3 
months; therefore, it was impossible to see regression of 
the lesions. Although systemic disease has not been 
associated with BCH, two articles have reported that BCH 
was associated with diabetes insipidus or insulin-depen-
dent diabetes mellitus
10,11. We did not find any association 
with other diseases in our case.
The histopathological features show well-circumscribed 
histiocytic infiltrates in the superficial to mid-reticular 
dermis. Cells were characterized by the presence of poly-
morphic nuclei, pale chromatin and abundant cytoplasm 
without cytoplasmic lipids. There are also inflammatory 
infiltrates composed of lymphocytes and rarely eosino-
phils. Although older lesions may contain giant cells, 
Touton giant cells or foam cells are not present
3. Electron 
microscopy showed worm-shaped or comma-shaped 
bodies in the cytoplasm of 5∼30% of the histiocytes. In 
contrast with Langerhans’ cell histiocytosis (LCH), Birbeck 
granules are absent
6. Immunohistochemical staining of 
lesional cells demonstrates positive staining for macrophage/ 
histiocytic markers, including factor XIIIa and CD68, 
whereas they remain negative for Langerhans markers, 
including S100 protein and CD1a
12.
BCH must primarily be differentiated from micronodular 
form of JXG and GEH
6,8. Furthermore, LCH, plane warts, 
urticaria pigmentosa, lichenoid sarcoidosis and multiple 
Spitz nevi can be confused with BCH. Plane wart, Spitz 
nevi, urticaria pigmentosa can be distinguished by 
histologic examination. Lesions of JXG are not usually 
limited to the head and neck, but rather are more widely 
distributed over the entire body. In addition, extracuta-
neous involvement occurs most significantly in the eyes. 
Histologic examination shows foamy cells and Touton 
giant cells
8,9. GEH is more common in adults, with a more 
extensive distribution of lesions and occasional mucosal 
involvement. The histologic appearance may be similar to 
BCH
13,14. LCH has more widespread skin and visceral 
organ involvement and are positive for S100 and CD1a. 
Ultrastructural studies also showed the presence of 
Birbeck granules in LCH
9.
Recent studies and case reports have indicated that BCH 
may have overlapping clinical and histologic features with 
JXG and GEH. Lesions of BCH was shown to transform 
into JXG in 2 cases
15,16. Sidwell et al. reported an infant 
with a congenital form of non-LCH with clinical and 
histologic features of both disseminated JXG and BCH
8. A 
case of GEH was also reported many years after complete 
regression of BCH
17. In addition, in a blinded histological 
study by Gianotti et al, 50% of BCH cases could not be 
definitely distinguished form GEH and early nonxan-
thomatous JXG
12. It has been suggested that BCH 
represents an abortive form of JXG rather than a separate 
entity
16,18. The occurrence of BCH as a localized form of 
GEH in children was rarely reported
13,19. The relationship 
of BCH with JXG and GEH is still not clear. Therefore, 
some authors have claimed that BCH, JXG and GEH 
belong to the same clinical entity. As a result, further 
research and data accumulation of cases are required to 
explain the relationship and pathogenesis between all of 
the non-Langerhans histiocytosis. 
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